The newly launched test complements a larger personalized medicine portfolio which includes, subject to regulatory approval in various countries, molecular tests related to transplantation, cancer and other therapies.
The new Olerup SSPO PCR assay was developed and manufactured by Olerup SSP. It is CE marked in Europe for in vitro diagnostic use and available for research use in other countries.
Peer Schatz, CEO of Qiagen, said: “Our new test is another great example for the advent of molecular diagnostic tests, which can be used to assess the efficacy of drugs.”